Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women

Gallup, 1984, Adenocarcinoma of the endometrium in women 40 years of age or younger, Obstet Gynecol, 64, 417 Soliman, 2005, Risk factors for young premenopausal women with endometrial cancer, Obstet Gynecol, 105, 575, 10.1097/01.AOG.0000154151.14516.f7 Emons, 1993, High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines, J Clin Endocrinol Metab, 77, 1458 Kinkel, 1999, Radiologic staging in patients with endometrial cancer: a meta-analysis, Radiology, 212, 711, 10.1148/radiology.212.3.r99au29711 ACOG Committee Opinion # 337, 2006, Noncontraceptive uses of levonorgestrel intrauterine device system, Obstet Gynecol, 107, 1479, 10.1097/00006250-200606000-00058 Toivonen, 1997, Progestin-releasing intrauterine devices, Curr Ther Endocrinol Metab, 6, 281 Kurman, 1982, Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma, Cancer, 49, 2547, 10.1002/1097-0142(19820615)49:12<2547::AID-CNCR2820491224>3.0.CO;2-0 Mutch, 2009, The new FIGO staging system for cancers of the vulva, cervix, endometrium and sarcomas, Gynecol Oncol, 115, 325, 10.1016/j.ygyno.2009.10.050 Guttinger, 2007, Endometrial effects of intrauterine levonorgestrel, Contraception, 75, S93, 10.1016/j.contraception.2007.01.015 Luukkainen, 1990, Levonorgestrel-releasing intrauterine device, Ann Med, 22, 85, 10.3109/07853899009147248 Signorelli, 2009, Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases, Br J Obstet Gynaecol, 116, 114, 10.1111/j.1471-0528.2008.02024.x Chiva de Agustín, 2008, Conservative management of patients with early endometrial carcinoma: a systematic review, Clin Transl Oncol, 10, 155, 10.1007/s12094-008-0173-1 Ramirez, 2004, Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review, Gynecol Oncol, 95, 133, 10.1016/j.ygyno.2004.06.045 Niwa, 2005, Outcome of fertility-preserving treatment in young women with endometrial carcinomas, Br J Obstet Gynaecol, 11, 317, 10.1111/j.1471-0528.2004.00398.x Wang, 2002, Fertility-preserving treatment in young patients with endometrial adenocarcinoma, Cancer, 94, 2192, 10.1002/cncr.10435 Montz, 2002, Intrauterine progesterone treatment of early endometrial cancer, Am J Obstet Gynecol, 186, 651, 10.1067/mob.2002.122130 Ørbo, 2008, Treatment results of endometrial hyperplasia after prospective D-score classification A follow-up study comparing effect of LNG-IUD and oral progestins versus observation only, Gynecol Oncol, 111, 68, 10.1016/j.ygyno.2008.06.014 Wildemeersch, 2007, Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up, Maturitas, 57, 210, 10.1016/j.maturitas.2006.12.004 Varma, 2008, The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia—a long-term follow-up study, Eur J Obstet Gynecol Reprod Biol, 139, 169, 10.1016/j.ejogrb.2008.02.022 Zaino, 2006, Reproducibility of the diagnosis of atypical endometrial hyperplasia, Cancer, 106, 804, 10.1002/cncr.21649 Creasman, 2001, Carcinoma of the corpus uteri: FIGO annual report on the result of treatment in gynaecological cancer, J Epidemiol Biostat, 6, 45 Zerbe, 2000, Inability of preoperative computed tomography scans to accuracy predict the extent of myometrial invasion and extracorporal spread in endometrial cancer, Gynecol Oncol, 78, 67, 10.1006/gyno.2000.5820 Horowitz, 2004, Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer, Gynecol Oncol, 95, 546, 10.1016/j.ygyno.2004.08.009 Takeshima, 1998, Ovarian metastasis in endometrial carcinoma, Gynecol Oncol, 70, 183, 10.1006/gyno.1998.5086 Morice, 2005, A need for laparoscopic evaluation of patients with endometrial carcinoma selected for conservative treatment, Gynecol Oncol, 96, 245, 10.1016/j.ygyno.2004.09.034 Frumovitz, 2006, Fertility-sapring therapy for young women with endometrial cancer, Expert Rev Anticancer Ther, 6, 27, 10.1586/14737140.6.1.27 Chyong-Huey, 2006, The role of hormones for the treatment of endometrial hyperplasia and endometrial cancer, Curr Opin Obstet Gynecol, 18, 29, 10.1097/01.gco.0000192994.37965.c6 Ota, 2005, Clinicopathologic study of uterine endometrial cancinoma in young women aged 40 years and younger, Int J Gynecol Cancer, 15, 657, 10.1136/ijgc-00009577-200507000-00012 Dhar, 2005, Is levonorgestrel intrauterine system effective for treatment of early endometrial cancer? Report of four cases and review of the literature, Gynecol Oncol, 97, 924, 10.1016/j.ygyno.2004.10.031 Leslie, 2005, Progesterone receptor isoform identification and subcellular localization in endometrial cancer, Gynecol Oncol, 96, 32, 10.1016/j.ygyno.2004.09.057 Wang, 2002, The relationship between telomere length and telomerase activity in gynecologic cancers, Gynecol Oncol, 84, 81, 10.1006/gyno.2001.6483